Department for Children and Adolescents, Division of Allergology, Pulmonology and Cystic fibrosis, Frankfurt am Main, Germany.
Department of Medicine and Surgery, Pediatric Clinic, University Hospital of Parma, Parma, Italy.
Pediatr Pulmonol. 2024 May;59(5):1321-1329. doi: 10.1002/ppul.26909. Epub 2024 Feb 14.
In preschoolers, performing an acceptable spirometry and measuring bronchodilator response (BDR) is challenging; in this context, impulse oscillometry (IOS) represents a valid alternative. However, more studies on the standardization of BDR for IOS in young children are required.
The objective of the study was to identify optimal thresholds to define a positive BDR test with IOS in preschoolers with suspected asthma.
Children aged 3-6 years with suspected asthma and their lung function investigated with both IOS and spirometry pre- and post-BDR were retrospectively analyzed. The spirometric BDR was defined as positive when the change of FEV was ≥12% or ≥200 mL. The oscillometric BDR was defined as positive in case of change of at least -40% in R5, +50% in X5, and -80% in AX.
Among 72 patients, 36 (age 5.2 ± 1 years; 64% boys) were selected for the subsequent analysis according to ATS/ERS quality criteria of measurements; specifically, 19 patients did not meet IOS and 36 did not meet spirometry criteria. The spirometric BDR was found positive in seven subjects (19.4%); conversely, a positive oscillometric BDR was identified in four patients (11.1%). No patient presented a positive BDR response with both methods. In IOS, the mean decrease in R5 and AX was 19.9% ± 10% and 44% ± 22.1%, and the mean increase in X5 was 23.3% ± 17.8%, respectively. A decrease in R5 of 25.7% (AUC 0.77, p = .03) and an increase in X5 of 25.7% (AUC 0.75, p = .04) showed the best combination of sensitivity and specificity to detect an increase of FEV ≥ 12% and/or ≥200 mL.
The IOS represents a valid alternative to spirometry to measure BDR in preschool children and should be the gold standard in this age group. We are considering a decrease of 26% in R5 and an increase of 26% in X5 as diagnostic threshold for BDR.
在学龄前儿童中,进行可接受的肺活量测定和测量支气管扩张剂反应(BDR)具有挑战性;在这种情况下,脉冲震荡测量法(IOS)是一种有效的替代方法。然而,需要更多关于 IOS 测量儿童 BDR 的标准化研究。
本研究的目的是确定在疑似哮喘的学龄前儿童中,使用 IOS 测量 BDR 的阳性最佳阈值。
回顾性分析了既往接受 IOS 和肺活量测定法检查且在 BDR 前后均怀疑患有哮喘的 3-6 岁儿童。当 FEV1 变化≥12%或≥200ml 时,将肺功能的支气管扩张剂反应定义为阳性。当 R5 至少下降 40%、X5 至少增加 50%、AX 至少下降 80%时,将 IOS 支气管扩张剂反应定义为阳性。
根据 ATS/ERS 测量质量标准,72 名患儿中 36 名(年龄 5.2±1 岁;64%为男性)符合后续分析标准;具体而言,19 名患儿 IOS 测量不达标,36 名患儿肺功能测量不达标。19 名患儿的支气管扩张剂反应(spirometric BDR)为阳性(19.4%);相反,4 名患儿的 IOS 支气管扩张剂反应(oscillometric BDR)为阳性(11.1%)。没有患儿同时通过两种方法检测出阳性 BDR 反应。在 IOS 中,R5 和 AX 的平均下降率分别为 19.9%±10%和 44%±22.1%,X5 的平均增加率为 23.3%±17.8%。R5 下降 25.7%(AUC 为 0.77,p=0.03)和 X5 增加 25.7%(AUC 为 0.75,p=0.04)的结果显示,可最好地结合敏感性和特异性,以检测出 FEV1 增加≥12%和/或≥200ml。
IOS 是一种在学龄前儿童中测量 BDR 的替代肺功能检测方法,应成为该年龄段的金标准。我们正在考虑将 R5 下降 26%和 X5 增加 26%作为 BDR 的诊断阈值。